Adam Koppel, Founder of Blueprint Medicines

Adam Koppel is the founder of Blueprint Medicines. Blueprint Medicines has raised $115M, latest Series C $50M (2014). Biotech · Cambridge, MA.

About Adam Koppel

Adam Koppel is the founder of Blueprint Medicines. Blueprint Medicines operates in Biotech and is based in Cambridge, MA. Blueprint Medicines has raised $115M, latest Series C $50M (2014). Backers on record include David Field, Clarus Ventures.

Adam Koppel at a glance

Company
Blueprint Medicines
Industry
Biotech
Location
Cambridge, MA
Total raised
$115M
Investors on record
David Field, Clarus Ventures

Frequently asked about Adam Koppel

Who is Adam Koppel?
Adam Koppel is the founder of Blueprint Medicines. Full profile, funding history and background on StartupFundraising.com.
What company did Adam Koppel found?
Adam Koppel founded Blueprint Medicines, a Biotech company based in Cambridge, MA.
How do I contact Adam Koppel?
Verified contact routes including LinkedIn, background and funding history for Adam Koppel are available on the StartupFundraising.com founder profile.

This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in Cambridge — who backed them, at what stage, and how much they raised.

More Biotech founders (40)

Browse related founder lists (5)

Full founder directory · Investor directory · Company funding database · Fundraising library